London, Jan. 22, 2021 (AltAfrica)-WHO is worried that Africa is in danger of being left behind as countries in other regions open make considerable progress in covid-19 vaccination, strike bilateral deals and drive up vaccine prices.

As of early this week, more than 40 million COVID-19 vaccine doses have been administered in 50 mostly high-income countries.

READ ALSO: MALI TO BUY 8.4 MILLION DOSES OF COVID-19 VACCINE

However, in Africa, Guinea is the sole low-income nation to provide vaccines and to date these have only been administered to 25 people. Seychelles, which is a high-income country, is the only one on the continent to start a national vaccination campaign.

Africa is in danger of being left behind in the race for #COVID19 vaccines as countries in other regions strike bilateral deals, driving up prices. @WHOAFRO, @UNICEFAfrica & @Gavi call for urgent access to safe & effective vaccines on the continent. ➡️https://t.co/Q3BawbpNSP pic.twitter.com/eFCaqSVO8Q

— WHO African Region (@WHOAFRO) January 21, 2021

“We first, not me first, is the only way to end the pandemic. Vaccine hoarding will only prolong the ordeal and delay Africa’s recovery. It is deeply unjust that the most vulnerable Africans are forced to wait for vaccines while lower-risk groups in rich countries are made safe,” said Dr Matshidiso Moeti, the World Health Organization (WHO) Regional Director for Africa.

“Health workers and vulnerable people in Africa need urgent access to safe and effective COVID-19 vaccines.” she lamented

According to the WHO vaccine introduction readiness assessment tool, African nations are on average 42% ready for their mass-vaccination campaigns, which is an improvement on the starting point of 33% two months ago. However, there is still a long way to go to reach the desired benchmark of 80%.

The COVAX Facility – which is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, and WHO – has secured 2 billion doses of vaccine from five producers, with options for over 1 billion more doses.

“COVAX is on track to start delivering vaccine doses and begin ensuring global access to vaccines, said Thabani Maphosa, Managing Director, Country Programmes, GAVI.”

This massive international undertaking has been made possible thanks to donations, work towards dose-sharing deals and deals with manufacturers that have brought us to almost 2 billion doses secured. We look forward to rollout in the coming weeks.”

In Africa, the coalition has committed to vaccinating at least 20% of the population by the end of 2021 by providing a maximum of 600 million doses based on two doses per individual disbursed in phases.

An initial 30 million doses are expected to start arriving in countries by March with the aim of covering 3% of the general population, prioritizing mainly healthcare workers and other priority groups and then expanding to cover additional vulnerable groups, such as the elderly and those with pre-existing conditions.

Most of the doses are expected to arrive in the second half of the year. These timelines and quantities could change if candidate vaccines fail to meet regulatory approval or production, delivery and funding face challenges.

All the 54 countries on the continent have expressed interest in the COVAX Facility.  Eight higher and middle-income countries will self-finance their own participation, while lower-middle income and low-income countries will access the vaccines at no cost through the Facility. The vaccines distributed by COVAX will have received WHO Emergency Use Listing authorization and as such will have undergone stringent validation of their safety and effectiveness. However, vaccine nationalism is threatening the COVAX initiative.

The COVAX initiative has raised US $6 billion in pledges but needs an additional US $2.8 billion in 2021 and WHO and partners are urging countries and donors to contribute and help end the pandemic globally.